Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST‐segment elevation myocardial infarction-Reference-Cited by-同舟云学术

Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST‐segment elevation myocardial infarction

Published:2020-01-22 Issue:5 Volume:24 Page:2717-2729
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Bøtker Hans Erik¹^ORCID,Cabrera‐Fuentes Hector Alejandro²³⁴⁵⁶,Ruiz‐Meana Marisol⁷⁸,Heusch Gerd⁹,Ovize Michel¹⁰

Affiliation:

1. Department of Cardiology Aarhus University Hospital Aarhus N Denmark

2. SingHealth Duke‐NUS Cardiovascular Sciences Academic Clinical Programme and Cardiovascular and Metabolic Disorders Program Duke‐National University of Singapore Medical School Singapore Singapore

3. National Heart Research Institute Singapore National Heart Centre Singapore Singapore

4. Institute of Biochemistry Medical School Justus‐Liebig University Giessen Germany

5. Tecnologico de Monterrey Centro de Biotecnologia‐FEMSA Monterrey Mexico

6. Institute of Fundamental Medicine and Biology Kazan (Volga Region) Federal University Kazan Russian Federation

7. Vall d'Hebron Institut de Recerca University Hospital Vall d'Hebron‐Universitat Autònoma Barcelona Spain

8. Centro de Investigación Biomédica en Red‐CV CIBER‐CV Spain

9. Institute for Pathophysiology West German Heart and Vascular Center University of Essen. Medical School Essen Germany

10. CarMeN Laboratory Hôpital Louis Pradel Hospices Civils de Lyon Université de Lyon and Explorations Fonctionnelles Cardiovasculaires INSERM U1060 Lyon France

Funder

Singapore Heart Foundation

Deutsche Forschungsgemeinschaft

Novo Nordisk Foundation Center for Basic Metabolic Research

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.14953

Reference129 articles.

1. Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014

2. National Trends in Heart Failure Hospitalization After Acute Myocardial Infarction for Medicare Beneficiaries

3. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge;Heusch G;Eur Heart J,2017

4. Targeting reperfusion injury in patients with ST‐segment elevation myocardial infarction: trials and tribulations;Hausenloy DJ;Eur Heart J,2017

5. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of platelet-derived mitochondrial transplantation in ischaemic heart disease;International Journal of Cardiology;2024-09

2. β3-Adrenergic receptor overexpression in cardiomyocytes preconditions mitochondria to withstand ischemia–reperfusion injury;Basic Research in Cardiology;2024-08-12

3. ALDH2 polymorphism and myocardial infarction: From alcohol metabolism to redox regulation;Pharmacology & Therapeutics;2024-07

4. Malonate given at reperfusion prevents post-myocardial infarction heart failure by decreasing ischemia/reperfusion injury;Basic Research in Cardiology;2024-06-12

5. Identification of a mechanism promoting mitochondrial sterol accumulation during myocardial ischemia–reperfusion: role of TSPO and STAR;Basic Research in Cardiology;2024-03-22